Fidelity MSCI Health Care Index ETF (FHLC)
| Assets | $2.93B |
| NAV | $65.70 |
| Expense Ratio | 0.08% |
| PE Ratio | 27.82 |
| Shares Out | 44.60M |
| Dividend (ttm) | $0.81 |
| Dividend Yield | 1.23% |
| Ex-Dividend Date | Sep 17, 2021 |
| 1-Year Return | - |
| Volume | 126,128 |
| Open | 65.98 |
| Previous Close | 65.76 |
| Day's Range | 65.60 - 66.20 |
| 52-Week Low | 49.88 |
| 52-Week High | 68.38 |
| Beta | 0.80 |
| Holdings | 477 |
| Inception Date | Oct 21, 2013 |
About FHLC
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
Top 10 Holdings
41.13% of assets| Name | Symbol | Weight |
|---|---|---|
| Johnson & Johnson | JNJ | 7.06% |
| UnitedHealth | UNH | 6.85% |
| Pfizer | PFE | 3.94% |
| Thermo Fisher Scientific | TMO | 3.92% |
| Abbott Laboratories | ABT | 3.65% |
| Merck | MRK | 3.37% |
| Danaher | DHR | 3.27% |
| Eli Lilly | LLY | 3.23% |
| AbbVie | ABBV | 3.15% |
| Medtronic | MDT | 2.69% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 17, 2021 | $0.190 | Sep 22, 2021 |
| Jun 18, 2021 | $0.183 | Jun 23, 2021 |
| Mar 19, 2021 | $0.201 | Mar 24, 2021 |
| Dec 18, 2020 | $0.234 | Dec 23, 2020 |
| Sep 18, 2020 | $0.176 | Sep 23, 2020 |
| Jun 19, 2020 | $0.173 | Jun 24, 2020 |
News
Healthcare ETFs on Radar As Q1 Earnings Unfold
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate...
Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause
Some biotech and pharmaceutical ETFs are gaining on Tuesday despite news that Johnson and Johnson's coronavirus vaccine has been halted in over two dozen states, after the Food and Drug Administration r...
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.
What Lies Ahead for Healthcare ETFs in Q2 Earnings?
The healthcare sector is expected to witness substantial earnings decline of 6.9% in the second quarter, representing the second strongest sector this earnings season.
Consumer Staples ETFs Slip As Philip Morris Drops
Philip Morris’s stock is dropping today along with the broad market as the company that makes Marlboro cigarettes told Irish retailers it made a “mistake” by showing an advertisement in the trade press ...
Healthcare ETFs Looks Strong Ahead of Q1 Earnings
The healthcare sector has been on a tear driven by potential vaccines and treatments for COVID-19.
What Lies Ahead for Healthcare ETFs in Q4 Earnings?
With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs.
Breakthrough In Vaping Related Illnesses May Be Boosting Healthcare, Biotech ETFs
The Vanguard Health Care ETF (VHT) and other healthcare ETFs have been trading higher amid news that U.S. health officials may finally have a potential discovery in the vaping illness outbreak that’s ki...
What's in Store for Healthcare ETFs in Q3 Earnings?
With earnings surprise in the cards, the healthcare sector is expected to witness modest earnings growth of 0.3% in the third quarter, suggesting some room for potential upside for healthcare ETFs.
E-Cigarette and Healthcare ETFs For Investors
The electronic cigarette market is a burgeoning global industry that includes vaping, and is forecast to expand from less than $10 billion now to over $50 billion by 2025, causing many to consider inves...
Q2 Earnings Surprise in the Cards, Healthcare ETFs to Buy
With earnings surprise in cards, the healthcare sector is expected to witness earnings growth of 1.7% in the second quarter, suggesting continued outperformance for healthcare ETFs.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Health-care stocks could rebound after their worst week of the year
Health care's sharp drop comes as investors worry that left-leaning policy ideas like universal health coverage are gaining support.
Can Q1 Earnings Lift Healthcare ETFs Higher?
With negative earnings revisions, the healthcare sector is expected to witness earnings growth of 1.8% in the first quarter, suggesting smooth trading for healthcare ETFs.